lexiara

1.

Actions meeting the objective laid down in point (a) of Article 4 Supporting the establishment and implementation of programmes assisting Member States and supporting the actions of Member States to improve health promotion and disease prevention; Supporting the implementation and further development of surveys, studies, collection of comparable data and statistics, where relevant including disaggregated data by gender and age, methodologies, classifications, microsimulations, pilot studies, indicators, knowledge brokering and benchmark exercises; Supporting Member States’ actions to put in place healthy and safe urban, work and school environments, to enable healthy life choices, to promote healthy diets and regular physical activity, taking into account the needs of vulnerable groups at every stage of their life, with the aim of promoting life-long health; Supporting Member States in delivering effective responses to communicable diseases, and in the prevention, surveillance, diagnosis and treatment of such diseases; Supporting Member States’ actions in health promotion and disease prevention throughout the lifetime of an individual and by addressing health risk factors, such as obesity, unhealthy diets and physical inactivity; Supporting actions to improve mental health; Supporting actions to complement measures of Member States in reducing damage to health due to illicit drug use and addiction, including information and prevention; Supporting implementing policies and actions to reduce health inequalities and inequities in relation to healthcare; Supporting actions to enhance health literacy; Supporting the promotion and implementation of the recommendations of the European Code against Cancer and supporting the revision of the current edition of that Code; Actions to support the implementation of cancer registries in all Member States; Furthering the cooperation among relevant national bodies of participating Member States with a view to supporting the creation of a virtual European network of excellence in order to strengthen research on all types of cancer, including paediatric cancer, and further the collection and exchange of clinical data and the translation of research findings into everyday care and treatment of cancer patients; Supporting actions to improve the quality of cancer care, including as regards prevention, screening, early diagnosis, monitoring and treatment, supportive and palliative care, in an integrative and patient-centred approach and supporting the establishment of quality assurance schemes for cancer centres or other centres treating cancer patients, including those treating paediatric cancer; Supporting the establishment of quality assurance schemes for cancer centres and centres treating cancer patients; Supporting mechanisms for cross-specialty capacity building and continuous education, in particular in the area of cancer care; Actions supporting the quality of life of cancer survivors and caregivers, including provision of psychological support, pain management and health-related aspects of professional reintegration; Strengthening collaboration on patient rights, patient safety and quality of care; Supporting actions regarding epidemiological surveillance, thus contributing to assessment of factors that affect or determine the health of people; Supporting, in synergy with other programmes, actions to improve the geographical distribution of the healthcare workforce and actions for the avoidance of ‘medical deserts’, without prejudice to Member State competences; Supporting the development of guidelines for preventing and managing communicable and non-communicable diseases, and of tools and networks for the exchange of best practices in that area; Supporting Member States’ actions to address health determinants, including reducing alcohol-related harm and tobacco use; Supporting tools and platforms to collect real-world evidence on the safety, effectiveness and impact of vaccines after use; Supporting initiatives to improve vaccination coverage rates in the Member States; Communication activities addressed to the public and stakeholders to promote Union action in the areas mentioned in this Annex; Awareness-raising campaigns and communications activities for the general public as well as for targeted groups, aimed at preventing and addressing vaccine hesitancy, misinformation and disinformation as regards prevention, causes and treatment of diseases, in a manner that complements national campaigns and communications activities on those matters; Communication activities addressed to the public on health risks and health determinants; Supporting actions to reduce the risk of healthcare-acquired infections.

· All articles ·

Source: EUR-Lex (Cellar) · retrieved 2026-11-07 · Text as adopted (Official Journal); later amendments are not incorporated in this text.